|4Feb 5, 4:49 PM ET

Badawi David 4

4 · Sight Sciences, Inc. · Filed Feb 5, 2026

Research Summary

AI-generated summary of this filing

Updated

Sight Sciences (SGHT) CTO David Badawi Receives RSU Award

What Happened David Badawi, Chief Technology Officer and Director of Sight Sciences (SGHT), received a grant of 64,915 restricted stock units (RSUs) on February 3, 2026. The award was recorded as an acquisition (grant) with no cash paid at grant ($0). The grant size was set at $420,000 divided by the closing share price on the grant date, producing the 64,915 RSU figure. Each RSU represents a contingent right to one share of common stock upon vesting.

Key Details

  • Transaction date: 2026-02-03; transaction type: A (award/grant).
  • Shares granted: 64,915 RSUs; grant value: $420,000 (based on closing price on 2026-02-03).
  • Vesting: 16 equal quarterly installments beginning March 31, 2026 and ending December 31, 2029, subject to continued service.
  • Shares owned after transaction (per filing footnote): 1,774,250 shares of common stock plus 202,938 RSUs that will be acquired upon future vesting.
  • No cash exchanged at grant; not an open-market buy or sale.
  • No indication in the filing that this was a late filing.

Context RSUs are a common form of executive compensation and do not convey actual shares until they vest; they are typically retained to incentivize continued service. This grant increases Badawi’s pool of unvested equity that will convert to common stock on scheduled vesting dates rather than representing an immediate purchase or sale.

Insider Transaction Report

Form 4
Period: 2026-02-03
Badawi David
DirectorChief Technology Officer
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-02-03+64,9151,977,188 total
Footnotes (2)
  • [F1]Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $420,000 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026.
  • [F2]Includes (i) 1,774,250 shares of Common Stock, and (ii) 202,938 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.
Signature
/s/Jeremy Hayden, Attorney-in-Fact for David Badawi|2026-02-05

Documents

1 file
  • 4
    ownership.xmlPrimary

    4